Effect of geometric remodeling on left ventricular longitudinal contractile reserve in patients with hypertension

Sungha Park1, Hye-Sun Seo, Chi Young Shim

  • 1Cardiology Division, Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Insights

Left ventricular hypertrophy (LVH) impairs heart function during exercise. This study found that hypertensive patients with LVH showed reduced longitudinal contractile reserve, indicating abnormal heart muscle response to stress.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Left ventricular hypertrophy (LVH) is linked to reduced coronary flow reserve.
  • Abnormal myocardial function during exercise may be associated with LVH.

Purpose of the Study:

  • To investigate the association between LVH and abnormal myocardial longitudinal function during exercise in hypertensive patients.

Main Methods:

  • 182 hypertensive patients underwent exercise testing.
  • Patients were categorized into normal geometry, concentric remodeling, and LVH groups.
  • E/E' ratio and mitral annular systolic velocity (S') were measured.

Main Results:

  • LVH patients had elevated E/E' at rest and during exercise.
  • Mitral annular systolic velocity (S') during exercise was significantly lower in the LVH group.
  • LV mass index and peak double product were independently associated with LV longitudinal contractile reserve.

Conclusions:

  • LVH is significantly associated with abnormal left ventricular longitudinal contractile reserve in hypertensive individuals.
  • Reduced longitudinal contractile reserve may contribute to exercise intolerance in hypertensive patients with LVH.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...